Genzyme and Medicines for Malaria Venture announced today a new collaboration with India’s Advinus Therapeutics.  The collaboration seeks to develop new, improved treatments for specific patient groups most at risk for malaria, an often fatal infectious disease of developing countries, particularly affecting pregnant women and infants. More›

Genzyme and Isis Pharmaceuticals, Inc. announced that they have begun a phase 3 study of mipomersen in patients with heterozygous familial hypercholesterolemia (heFH), a genetic disorder that causes exceptionally high levels of LDL cholesterol. More›

Genzyme Corporation today reported strong sales and profit growth in the second quarter, along with significant progress in its commercial and clinical programs. More›